“…In this work, we have attempted to characterize the mode of action of VIP on tracheobronchial smooth muscle by measuring VIP-mediated cyclic adenosine 3',5'-monophosphate (cyclic AMP) accumulation in this tissue. A number of agents stimulate the production of cyclic AMP, or inhibit its degradation, in the airways (Andersson, Bergh & Svedmyr, 1972;Inamasu, Shinjo, Iwasawa & Morita, 1974;Murad, 1974;Duncan, Griffin & Solomon, 1975;Ohkubo, Takayanagi & Takagi, 1976;Triner, Velliemoz & Verosky, 1977), and these actions may be related to their ability to produce bronchodilatation (Said et al, 1974;Andersson et al, 1972;Inamasu et al, 1974;Murad, 1974;Duncan et al, 1975;Ohkubo et al, 1976;Triner, et al, 1977). The bronchodilator action of VIP is of special interest in view of the recent demonstration that a VIP-like peptide occurs in normal lung tissue (Said & Mutt, 1977).…”